Director Pardo buys 312,500 SGP shares at $16.00 ($5.0M) as part of 14-insider cluster buy pattern within 14 days
Director Geoffrey B Pardo purchased 312,500 shares of SpyGlass Pharma at $16.00, increasing his position from 1,875,013 to 2,187,513 shares (a +16.7% increase). This transaction is part of a cluster pattern: 14 other insiders also bought within the past 14 days, indicating coordinated or simultaneous buying interest across the insider group. The stock has appreciated to $27.55 as of 2026-02-11 (4 trading days after the purchase), though the recent listing status means near-term price momentum should be interpreted cautiously. The filing contains a derivative-conversion transaction (Table II), so Pardo's complete economic position extends beyond the Table I shares reflected here.
Director Geoffrey B Pardo bought 100,000 shares of SI at $15.00 ($1.5M); cluster pattern: 6 other insiders also bought in 14 days.
Director Geoffrey B Pardo purchased 100,000 shares of Shoulder Innovations, Inc. at $15.00 on 2025-08-01, investing $1,500,000.00 in a recently listed company (4 trading days old). This transaction is part of a cluster buy pattern in which 6 other insiders also bought within the past 14 days, suggesting coordinated or synchronized confidence across the leadership group during the immediate post-IPO window. The company's current price of $14.16 (as of 2025-08-05) represents a modest decline from the transaction price, typical volatility for a fresh listing. The presence of derivative securities indicated in Table II (not yet populated in our database) suggests Pardo's full equity position extends beyond the 7,666 shares shown in Table I, warranting attention to the complete ownership picture once derivative holdings are disclosed.
